Korean enforcer sanctions drugmaker for anticompetitive rebate scheme

A Korean drugmaker broke competition rules by bribing healthcare professionals with cash and gifts to prescribe patients with its products, the country’s antitrust watchdog has said.

Unlock unlimited access to all Global Competition Review content